TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Athersys, Inc. (NASDAQ: ATHX) Investor Investigation Concerning Possible Securities Laws Violations Announced

  • Investors who purchased shares of Athersys, Inc. (NASDAQ: ATHX), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Athersys, Inc.
Security
NASDAQ: ATHX

Summary

An investigation on behalf of investors of Athersys, Inc. (NASDAQ: ATHX) shares over potential securities laws violations by Athersys, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Athersys, Inc. (NASDAQ: ATHX) concerning whether a series of statements by Athersys, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Cleveland, OH based Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Athersys, Inc. reported that its annual Total Revenue declined from $17.34 million in 2016 to $3.7 million in 2017 and that its Net Loss increased from $15.02 million in 2016 to $33.28 million in 2017.

Shares of Athersys, Inc. (NASDAQ: ATHX) declined from $2.63 per share in September 2017 to $1.29 per share in February 2018.

Start Monitoring Your Investments